Biotech Values

[ghmm]

Nothing newsworthy is happening on the Copaxone program, which is in litigation with Teva.

Craig Wheeler had said one could follow whats going on by looking at the various legal filings. I am not sure where to look but on seeing the price movement today one thing I suspected was perhaps something in there looks favorable to Momenta.